T1	Participants 54 84	chronic hepatic encephalopathy
T2	Participants 410 569	patients were administered, in addition to their diet, branched-chain amino acids (0.24 g/kg, 30 patients) or an equinitrogenous amount of casein (34 patients)
T3	Participants 137 172	The Italian Multicenter Study Group
T4	Participants 1683 1729	cirrhotic patients with chronic encephalopathy
T5	Participants 292 335	chronic hepatic encephalopathy in cirrhosis
